Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Retained Earnings (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Retained Earnings for 16 consecutive years, with -$12.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings rose 92.13% to -$12.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$12.4 million, a 92.13% increase, with the full-year FY2024 number at -$158.0 million, down 8.52% from a year prior.
  • Retained Earnings was -$12.4 million for Q3 2025 at Harvard Bioscience, down from -$11.7 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$10.0 million in Q4 2021 to a low of -$158.0 million in Q3 2024.
  • A 5-year average of -$56.7 million and a median of -$15.0 million in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: plummeted 976.4% in 2023, then soared 92.36% in 2025.
  • Harvard Bioscience's Retained Earnings stood at -$10.0 million in 2021, then tumbled by 50.11% to -$15.1 million in 2022, then crashed by 867.35% to -$145.6 million in 2023, then dropped by 8.52% to -$158.0 million in 2024, then skyrocketed by 92.13% to -$12.4 million in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Retained Earnings are -$12.4 million (Q3 2025), -$11.7 million (Q2 2025), and -$14.4 million (Q1 2025).